A peer-reviewed journal that offers evidence-based clinical information and continuing education for dentists.

Pfizer Says Booster Shot Against COVID-19 Variants Is in Development


As new, more infectious variants to the novel coronavirus spread across the world, Pfizer, in collaboration with its partner BioNTech, is developing a booster shot that would offer protection against new strains that may evolve. The company asserts that its two-dose vaccine provides immunity to currently circulating variants of SARS-CoV-2, but wants to be prepared should the level of immunity provided begin to diminish. Moderna is also working on a booster to its two-dose vaccine after preliminary data show the immunity provided is reduced in the presence of the South African variation of the novel coronavirus. Click here to read more.

Leave A Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy